Pearl Global Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 15, 2025, 4:06 pm

Competitors of Pearl Global Industries Ltd

All Competitor Stocks of Pearl Global Industries Ltd

Quarterly Result

Last Updated: August 20, 2025, 5:40 am

Below is a detailed analysis of the quarterly data for Pearl Global Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,228.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,229.00 Cr. (Mar 2025) to 1,228.00 Cr., marking a decrease of 1.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,116.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,112.00 Cr. (Mar 2025) to 1,116.00 Cr., marking an increase of 4.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 112.00 Cr.. The value appears to be declining and may need further review. It has decreased from 117.00 Cr. (Mar 2025) to 112.00 Cr., marking a decrease of 5.00 Cr..
• For OPM %, as of Jun 2025, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 10.00% (Mar 2025) to 9.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00 Cr..
• For Depreciation, as of Jun 2025, the value is 20.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 21.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 76.00 Cr.. The value appears to be declining and may need further review. It has decreased from 78.00 Cr. (Mar 2025) to 76.00 Cr., marking a decrease of 2.00 Cr..
• For Tax %, as of Jun 2025, the value is 14.00%. The value appears to be improving (decreasing) as expected. It has decreased from 16.00% (Mar 2025) to 14.00%, marking a decrease of 2.00%.
• For Net Profit, as of Jun 2025, the value is 66.00 Cr.. The value appears strong and on an upward trend. It has increased from 65.00 Cr. (Mar 2025) to 66.00 Cr., marking an increase of 1.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 14.76. The value appears to be declining and may need further review. It has decreased from 14.86 (Mar 2025) to 14.76, marking a decrease of 0.10.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:18 pm

Growth

Last Updated: September 5, 2025, 12:10 pm

Balance Sheet

Last Updated: July 25, 2025, 2:36 pm

Below is a detailed analysis of the balance sheet data for Pearl Global Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2024) to 23.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,133.00 Cr.. The value appears strong and on an upward trend. It has increased from 780.00 Cr. (Mar 2024) to 1,133.00 Cr., marking an increase of 353.00 Cr..
• For Borrowings, as of Mar 2025, the value is 773.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 588.00 Cr. (Mar 2024) to 773.00 Cr., marking an increase of 185.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 667.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 595.00 Cr. (Mar 2024) to 667.00 Cr., marking an increase of 72.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,595.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,985.00 Cr. (Mar 2024) to 2,595.00 Cr., marking an increase of 610.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 727.00 Cr.. The value appears strong and on an upward trend. It has increased from 612.00 Cr. (Mar 2024) to 727.00 Cr., marking an increase of 115.00 Cr..
• For CWIP, as of Mar 2025, the value is 44.00 Cr.. The value appears strong and on an upward trend. It has increased from 35.00 Cr. (Mar 2024) to 44.00 Cr., marking an increase of 9.00 Cr..
• For Investments, as of Mar 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 30.00 Cr. (Mar 2024) to 24.00 Cr., marking a decrease of 6.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,800.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,309.00 Cr. (Mar 2024) to 1,800.00 Cr., marking an increase of 491.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,595.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,985.00 Cr. (Mar 2024) to 2,595.00 Cr., marking an increase of 610.00 Cr..

Notably, the Reserves (1,133.00 Cr.) exceed the Borrowings (773.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Pearl Global Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 54.96. This value is within the healthy range. It has increased from 40.26 (Mar 24) to 54.96, marking an increase of 14.70.
• For Diluted EPS (Rs.), as of Mar 25, the value is 52.87. This value is within the healthy range. It has increased from 40.05 (Mar 24) to 52.87, marking an increase of 12.82.
• For Cash EPS (Rs.), as of Mar 25, the value is 66.61. This value is within the healthy range. It has increased from 53.53 (Mar 24) to 66.61, marking an increase of 13.08.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 251.59. It has increased from 187.56 (Mar 24) to 251.59, marking an increase of 64.03.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 251.59. It has increased from 187.56 (Mar 24) to 251.59, marking an increase of 64.03.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 981.01. It has increased from 788.40 (Mar 24) to 981.01, marking an increase of 192.61.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 95.17. This value is within the healthy range. It has increased from 78.05 (Mar 24) to 95.17, marking an increase of 17.12.
• For PBIT / Share (Rs.), as of Mar 25, the value is 78.80. This value is within the healthy range. It has increased from 63.32 (Mar 24) to 78.80, marking an increase of 15.48.
• For PBT / Share (Rs.), as of Mar 25, the value is 58.20. This value is within the healthy range. It has increased from 44.07 (Mar 24) to 58.20, marking an increase of 14.13.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 50.24. This value is within the healthy range. It has increased from 38.80 (Mar 24) to 50.24, marking an increase of 11.44.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 54.06. This value is within the healthy range. It has increased from 40.11 (Mar 24) to 54.06, marking an increase of 13.95.
• For PBDIT Margin (%), as of Mar 25, the value is 9.70. This value is below the healthy minimum of 10. It has decreased from 9.89 (Mar 24) to 9.70, marking a decrease of 0.19.
• For PBIT Margin (%), as of Mar 25, the value is 8.03. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 8.03.
• For PBT Margin (%), as of Mar 25, the value is 5.93. This value is below the healthy minimum of 10. It has increased from 5.58 (Mar 24) to 5.93, marking an increase of 0.35.
• For Net Profit Margin (%), as of Mar 25, the value is 5.12. This value is within the healthy range. It has increased from 4.92 (Mar 24) to 5.12, marking an increase of 0.20.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.51. This value is below the healthy minimum of 8. It has increased from 5.08 (Mar 24) to 5.51, marking an increase of 0.43.
• For Return on Networth / Equity (%), as of Mar 25, the value is 21.48. This value is within the healthy range. It has decreased from 21.79 (Mar 24) to 21.48, marking a decrease of 0.31.
• For Return on Capital Employeed (%), as of Mar 25, the value is 24.49. This value is within the healthy range. It has decreased from 25.03 (Mar 24) to 24.49, marking a decrease of 0.54.
• For Return On Assets (%), as of Mar 25, the value is 9.56. This value is within the healthy range. It has increased from 8.80 (Mar 24) to 9.56, marking an increase of 0.76.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 0.2. It has decreased from 0.12 (Mar 24) to 0.06, marking a decrease of 0.06.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.47. This value is within the healthy range. It has decreased from 0.55 (Mar 24) to 0.47, marking a decrease of 0.08.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.97. It has increased from 1.82 (Mar 24) to 1.97, marking an increase of 0.15.
• For Current Ratio (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has increased from 1.45 (Mar 24) to 1.57, marking an increase of 0.12.
• For Quick Ratio (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has increased from 0.87 (Mar 24) to 0.94, marking an increase of 0.07.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.07. This value is below the healthy minimum of 4. It has increased from 3.04 (Mar 24) to 3.07, marking an increase of 0.03.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 27.96 (Mar 24) to 0.00, marking a decrease of 27.96.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 20.45 (Mar 24) to 0.00, marking a decrease of 20.45.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 72.04 (Mar 24) to 0.00, marking a decrease of 72.04.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 79.55 (Mar 24) to 0.00, marking a decrease of 79.55.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.41. This value is within the healthy range. It has increased from 4.08 (Mar 24) to 4.41, marking an increase of 0.33.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.28. This value is within the healthy range. It has increased from 3.04 (Mar 24) to 3.28, marking an increase of 0.24.
• For Enterprise Value (Cr.), as of Mar 25, the value is 6,019.87. It has increased from 2,448.25 (Mar 24) to 6,019.87, marking an increase of 3,571.62.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.34. This value is within the healthy range. It has increased from 0.71 (Mar 24) to 1.34, marking an increase of 0.63.
• For EV / EBITDA (X), as of Mar 25, the value is 13.77. This value is within the healthy range. It has increased from 7.20 (Mar 24) to 13.77, marking an increase of 6.57.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.34. This value is within the healthy range. It has increased from 0.68 (Mar 24) to 1.34, marking an increase of 0.66.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 72.03 (Mar 24) to 0.00, marking a decrease of 72.03.
• For Price / BV (X), as of Mar 25, the value is 5.23. This value exceeds the healthy maximum of 3. It has increased from 2.94 (Mar 24) to 5.23, marking an increase of 2.29.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.34. This value is within the healthy range. It has increased from 0.68 (Mar 24) to 1.34, marking an increase of 0.66.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 24) to 0.04, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness